MedTrace Logo

Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia

NCT01471275 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2011-12-06

No results posted yet for this study

Summary

With metformin for the control, evaluate the safety and efficacy of Jiangtangtiaozhi decoction in treatment of obesity with type 2 diabetes, dyslipidemia

Conditions

  • Type 2 Diabetes Mellitus ;Obesity,High Triglycerides；TCM

Interventions

DRUG

Metformin

250 mg or 500mg three times a day

DRUG

Jiangtangtiaozhi decoction

15 grams each time, twice a day, with boiled water

Sponsors & Collaborators

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Xiaolin Tong · China academy of Chinese medical science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01471275 on ClinicalTrials.gov